Drug intelligence / Profile preview

Adrien Gagnon Probiotic 7 Billion

Development stage: Unknown
Lead developer: Adrien Gagnon
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Adrien Gagnon Probiotic 7 Billion is a multi-strain probiotic dietary supplement formulated to support intestinal health and maintain a balanced gut microbiota. It typically contains a blend of five probiotic strains, including *Lactobacillus acidophilus*, *Lactobacillus rhamnosus*, *Lactobacillus casei*, *Bifidobacterium longum*, and *Bifidobacterium bifidum*, providing a total of 7 billion colony-forming units (CFU) per dose. The product is utilized in clinical research to evaluate its efficacy in mitigating antibiotic-associated dysbiosis and modulating the gut resistome (the collection of antimicrobial resistance genes) in individuals undergoing treatment with antibiotics such as amoxicillin/clavulanate (Augmentin). It is developed and marketed by Adrien Gagnon, a Canadian company specializing in natural health products.

Brand names: Adrien Gagnon Probiotic 7 Billion
Other names: Adrien Gagnon Probiotique 7 Milliards

Beyond the preview

Go deeper on Adrien Gagnon Probiotic 7 Billion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adrien Gagnon Probiotic 7 Billion.

Explore the full profile